Terminated NA INTERVENTIONAL 2-arm NCT01690572

Drug Eluting Balloon for Prevention of Constrictive Remodeling

Drug Coated Balloon (DCB) for the Prevention of Constrictive Remodeling and Restenosis in Small Vessel Coronary Disease

Sponsor: Prof. Dr. med. Christoph Hehrlein

Conditions Coronary Disease Diabetes Mellitus

Interventions Paclitaxel coated balloon catheter uncoated balloon catheter sprinter legend

Updated 7 times since 2017 Last updated: Apr 27, 2017 Started: Oct 31, 2012 Primary completion: Dec 31, 2016 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

recruitment was not sufficient.

Other Coronary Disease trials with similar outcome

Browse all Coronary Disease trials

This NA trial investigates Coronary Disease and Diabetes Mellitus and is currently terminated or withdrawn. Prof. Dr. med. Christoph Hehrlein leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 2 earlier versions

May 2017 — Jun 2018 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jan 2017 — May 2017 [monthly]

Recruiting NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Prof. Dr. med. Christoph Hehrlein

Data source: Herz-Zentrums Bad Krozingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Freiburg im Breisgau, Germany